[1]
“Oral and Skin Pigmentations associated with hydroxyurea therapeutic doses in a patient with sickle cell disease: Case Report”, joms, vol. 18, no. 1, pp. 31–34, Jun. 2023, doi: 10.51984/joms.v18i1.2606.